NEW YORK, May 4 (GenomeWeb News) - HTG today said that Merck has licensed its ArrayPlate qNPA (quantitative nuclease protection assay) technology for its drug discovery research.

ArrayPlate qNPA offers multiplexed measurement of 16 mRNA species in each well of a standard 96-well microplate, HTG said.

HTG did not provide financial details of the licensing agreement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.